Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Mar 10.
Published in final edited form as: Biol Blood Marrow Transplant. 2008 Jan;15(1 Suppl):137–138. doi: 10.1016/j.bbmt.2008.11.007

Pathobiology of Inflammation to cell death

Kenneth L Rock 1
PMCID: PMC2653866  NIHMSID: NIHMS89443  PMID: 19147093

When a cell dies in vivo the innate immune system investigates the scene of the crime. If the death of the cell is physiological, e.g. as part of normal cell turn over, then the corpse is cleared and little else is done. In fact, as part of this process phagocytes that ingest normal apoptotic cells can actively suppress tissue responses by elaborating anti-inflammatory cytokines (1). However, if the cell has died unexpectedly from some pathological process, then the innate immune system expands its investigation.

The earliest response to abnormal cell death is an acute inflammatory response. In this process dead cells stimulate the production of proinflammatory mediators by monocyte/macrophages that result in increased blood flow, leakage of protein-rich fluid from venules and recruitment of neutrophils followed by monocytes into the site of damage (2). The recruited leukocytes attempt to clear the corpses and stimulate tissue repair. This process resolves once the stimulus (cell death and/or associated factors) driving these events cease and the damage is repaired. Recently, IL-1 was shown to be a key mediator for the recruitment of neutrophils (3). However, other innate mechanisms that sense abnormal cell death and the mediators that orchestrate the inflammatory response in this setting are not well understood.

In parallel to the inflammatory process, the innate immune system may also mobilize the adaptive immune system to respond to antigens associated with dying cells. As part of this process dendritic cells internalize antigens from dead cells and present them as peptides bound to MHC class I and MHC class II molecules (4). In addition, dead cells can stimulate dendritic cells to migrate to secondary lymphoid tissue and mature into an immunostimulatory state (5). Through these mechanisms dendritic cells alert T cells to potential pathological situations in the peripheral tissues that are causing cells to die. If CD4 or CD8 T cells recognize antigenic peptides presented on the MHC molecules of the mature and stimulatory dendritic cells, then an adaptive immune response is initiated.

Why are the innate and adaptive immune systems so concerned with cell death? The current notion is that if cells are dying under non-physiological conditions then there is an underlying pathological process and this is potentially dangerous to the host. According to this idea the innate immune system evolved mechanisms to detect this potential danger (6, 7). When death is detected, the ensuing acute inflammatory response rapidly delivers the soluble and cellular defenses that attempt to neutralize or wall off the injurious process and ultimately repair the damage. Similarly, cell death alerts the adaptive immune system to a potential problem in ways that will mobilize this arm of the immune system if immunogenic antigens are present.

These immune responses are double-edged swords. On the one hand, they rapidly mobilize host defense to the potential problem before it gets out of control. On the other hand, the acute inflammatory response is indiscriminant and can damage normal tissue (7). While this may be a small price to pay for containing an injurious process, there are many settings where the recruited response is of no benefit (e.g. in a sterile ischemic infarct there is nothing to defend against) and actually may make the situation worse. In fact, the cell death-induced inflammatory response is thought to contribute to the pathogenesis of a number of diseases. Similarly in individuals that are so predisposed, dead cells may help to stimulate adaptive response to autologous antigens and contribute to the development of autoimmunity. Given these “costs” and “benefits” the innate immune response to dying cells is medically important.

Precisely how the innate system recognizes cell death and discriminates between normal physiological versus pathological cell death is not fully understood. Apoptotic cells express “eat me” signals like phosphatidyl serine on the outer leaflet of the plasma membrane that cause phagocytes to ingest these cells and produce anti-inflammatory mediators such as TGFβ and IL-10 (1). In contrast, necrotic cells typically provoke inflammatory responses (and adaptive ones if antigens are present). Therefore, one of the factors that influence the host response is the mechanism of cell death. However, in some situations apoptotic cells will also stimulate inflammation and promote the generation of T cell responses.

In some cases, responses to dying cells will be stimulated in part by the underlying pathological process, e.g. in infections where cytopathic microbes are causing cells to die. In such a situation, pattern recognitions receptors, such as the Toll-like receptors (TLR) on leukocytes, can recognize microbial molecules and stimulate inflammation and adaptive immune responses (8). However, cell death (e.g. in sterile situations) is in and of itself sufficient to trigger these responses (7). It is thought that this is because the innate immune system has evolved mechanisms to detect the exposure or release of intracellular molecules that in living cells are normally hidden from view (9). Thus the release of these intracellular molecules is a sign of cell damage and potential danger. These immunostimulatory molecules are collectively referred to as Danger Signals or Damage-Associated Molecular Patterns (DAMPs).

The number of different kinds of Danger Signals in cells is unknown. Thus far, several putative DAMPs have been identified. These molecules include uric acid, high mobility group box 1 (HMGB1) protein, non-muscle myosin heavy chains, heat shock proteins, and some other molecules. Moreover, there are almost certainly more DAMPs yet to be discovered (see (9)for review). Some DAMPs may directly stimulate leukocytes while others may work by generating mediators from extracellular components by cleaving extracellular matrix proteins or activating complement. There is also relatively limited information about what receptors sense the release of DAMPs and stimulate the immune responses. There is evidence that TLR 2 and 4 sense cell death and in particular HMGB1, but these molecules appear to play a relatively minor role in triggering the inflammatory response to dying cells(3). There is also evidence that the intracellular pattern recognition receptor, NLRP3 (NALP3, cyropyrin), is involved in the generation of IL-1β and inflammatory responses to the DAMP uric acid (10), but its role in responses to dying cells is not yet known.

Ultimately to understand the inflammatory response to cell death it will be necessary to identify the various DAMPs that trigger this process and elucidate the pathways they stimulate. This will be important to understand the biology of these responses and how they contribute to health and disease. Moreover, since cell death-induced immune responses contribute to disease pathogenesis, these pathways are potentially molecular targets for therapeutics to modulate the cell death-induced immune responses.

Acknowledgments

This work was supported by grants from the NIH and the Diabetes Endocrinology Research Center Grant DK32520. Critical reading of the manuscript by Hajime Kono and Ferndado Ontiveros is gratefully acknowledged.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Bibliography

  • 1.Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest. 2002;109:41. doi: 10.1172/JCI11638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Majno G, Joris I. Cells, Tissues and Disease. Oxford University Press; 2004. [Google Scholar]
  • 3.Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med. 2007;13:851. doi: 10.1038/nm1603. [DOI] [PubMed] [Google Scholar]
  • 4.Rock KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev. 2005;207:166. doi: 10.1111/j.0105-2896.2005.00301.x. [DOI] [PubMed] [Google Scholar]
  • 5.Shi Y, Rock KL. Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens. Eur J Immunol. 2002;32:155. doi: 10.1002/1521-4141(200201)32:1<155::AID-IMMU155>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  • 6.Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immun. 1994;12:991. doi: 10.1146/annurev.iy.12.040194.005015. [DOI] [PubMed] [Google Scholar]
  • 7.Rock KL, Kono H. The Inflammatory Response to Cell Death. Annu Rev Pathol. 2007;3:99. doi: 10.1146/annurev.pathmechdis.3.121806.151456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335. doi: 10.1146/annurev.immunol.21.120601.141126. [DOI] [PubMed] [Google Scholar]
  • 9.Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol. 2008;8:279. doi: 10.1038/nri2215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237. doi: 10.1038/nature04516. [DOI] [PubMed] [Google Scholar]

RESOURCES